Idit Lachover Roth

Dr. Idit Lachover Roth


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2018 in Science Immunology
Verified
Journal Article
Closed access
PDF file
SFStefanie Frey-Jakobs
Stefanie Frey-Jakobs
JHJulia M. Hartberger
Julia M. Hartberger
MFManfred Fliegauf
Manfred Fliegauf
CBClaudia Bossen
Claudia Bossen
MWMagdalena L. Wehmeyer
Magdalena L. Wehmeyer
BGBodo Grimbacher
Bodo Grimbacher
Homozygous nonsense mutations in ZNF341 impair its ability to activate STAT3 transcription and thereby cause immunodeficiency.

28 October 2022 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
IRIdit Lachover Roth
Idit Lachover Roth
ACAnat Cohen-Engler
Anat Cohen-Engler
YFYael Furman
Yael Furman
ISIdo Shachar
Ido Shachar
YRYossi Rosman
Yossi Rosman
RCRonit Confino-Cohen
Ronit Confino-Cohen

1 January 2019 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
IRIdit Lachover Roth
Idit Lachover Roth
SSShoshan Sharon
Shoshan Sharon
YRYossi Rosman
Yossi Rosman
KMKeren Meir-Shafrir
Keren Meir-Shafrir
RCRonit Confino-Cohen
Ronit Confino-Cohen

27 January 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
IRIdit Lachover Roth
Idit Lachover Roth
ARAhmad Rabie
Ahmad Rabie
ACAnat Cohen-Engler
Anat Cohen-Engler
YRYossi Rosman
Yossi Rosman
KMKeren Meir-Shafrir
Keren Meir-Shafrir
RCRonit Confino-Cohen
Ronit Confino-Cohen

14 July 2020 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
IRIdit Lachover Roth
Idit Lachover Roth
PSPazit salamon
Pazit salamon
TFTal Freund
Tal Freund
YGYael Ben-David Gadot
Yael Ben-David Gadot
SBSzilvia Baron
Szilvia Baron
DHDavid Hagin
David Hagin

19 September 2024 in Blood
Verified
Journal Article
Closed access
BWBaruch Wolach
Baruch Wolach
RGRonit Gavrieli
Ronit Gavrieli
OWOfir Wolach
Ofir Wolach
PSPazit Salamon
Pazit Salamon
MBMartin de Boer
Martin de Boer
IRIdit Lachover Roth
Idit Lachover Roth
Neutrophils are the first line of defense against invading pathogens. Neutrophils execute and modulate immune responses by generating reactive oxygen species (ROS). Chronic granulomatous disease (CGD) is a primary immune deficiency disorder of phagocytes, caused by inherited mutations in the genes of the nicotinamide adenine dinucleotide phosphate reduced oxidase enzyme. These mutations lead to failure of ROS generation followed by recurrent bacterial and fungal infections, frequently associated with hyperinflammatory manifestations. We report a multicenter cumulative experience in diagnosing and treating patients with CGD. From 1986 to 2021, 2918 patients experiencing frequent infections were referred for neutrophil evaluation. Among them, 110 patients were diagnosed with CGD: 56 of Jewish ancestry, 48 of Arabic ancestry, and 6 of non-Jewish/non-Arabic ancestry. As opposed to other Western countries, the autosomal recessive (AR) CGD subtypes were predominant in Israel (71/110 patients). Thirty-nine patients had X-linked CGD, in most patients associated with severe infections (clinical severity score ≥3) and poor outcomes, presenting at a significantly earlier age than AR-CGD subtypes. The full spectrum of infections and hyperinflammatory manifestations is described. Six patients had hypomorphic mutations with significantly milder phenotype, clinical severity score ≤2, and better outcomes. Hematopoietic stem cell transplantation was implemented in 39 of 110 patients (35.5%). Successful engraftment was achieved in 92%, with 82% long-term survival and 71% full clinical recovery. CGD is a complex disorder requiring a multiprofessional team. Early identification of the genetic mutation is essential for prompt diagnosis, suitable management, and prevention.